Global G-CSF Biosimilars Market Research Report 2019 (Includes Business Impact of COVID-19)
- TBI149435
- March 20, 2019
- Global
- 103 pages
- QY Market Research
Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for G-CSF Biosimilars in US$ by the following Product Segments: Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor
Company profiles are primarily based on public domain information including company
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
Pfizer
Novartis
Roche
The global G-CSF Biosimilars market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on G-CSF Biosimilars volume and value at global level, regional level and company level. From a global perspective, this report represents overall G-CSF Biosimilars market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Pfizer
Novartis
Roche
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Segment by Application
Blood Disorders
Oncology Diseases
Chronic And Autoimmune Diseases
Growth Hormone Deficiencies
Table of Contents
Executive Summary
1 G-CSF Biosimilars Market Overview
1.1 Product Overview and Scope of G-CSF Biosimilars
1.2 G-CSF Biosimilars Segment by Type
1.2.1 Global G-CSF Biosimilars Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Human Growth Hormone
1.2.3 Erythropoietin
1.2.4 Monoclonal Antibodies
1.2.5 Insulin
1.2.6 Interferon
1.2.7 Granulocyte-Colony Stimulating Factor
1.3 G-CSF Biosimilars Segment by Application
1.3.1 G-CSF Biosimilars Consumption Comparison by Application (2014-2025)
1.3.2 Blood Disorders
1.3.3 Oncology Diseases
1.3.4 Chronic And Autoimmune Diseases
1.3.5 Growth Hormone Deficiencies
1.4 Global G-CSF Biosimilars Market by Region
1.4.1 Global G-CSF Biosimilars Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global G-CSF Biosimilars Market Size
1.5.1 Global G-CSF Biosimilars Revenue (2014-2025)
1.5.2 Global G-CSF Biosimilars Production (2014-2025)
2 Global G-CSF Biosimilars Market Competition by Manufacturers
2.1 Global G-CSF Biosimilars Production Market Share by Manufacturers (2014-2019)
2.2 Global G-CSF Biosimilars Revenue Share by Manufacturers (2014-2019)
2.3 Global G-CSF Biosimilars Average Price by Manufacturers (2014-2019)
2.4 Manufacturers G-CSF Biosimilars Production Sites, Area Served, Product Types
2.5 G-CSF Biosimilars Market Competitive Situation and Trends
2.5.1 G-CSF Biosimilars Market Concentration Rate
2.5.2 G-CSF Biosimilars Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global G-CSF Biosimilars Production Market Share by Regions
3.1 Global G-CSF Biosimilars Production Market Share by Regions
3.2 Global G-CSF Biosimilars Revenue Market Share by Regions (2014-2019)
3.3 Global G-CSF Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America G-CSF ...
| read more...
Related Reports
Global GDPR Compliance Solutions Market and Forecast 2020-2026
Published : 07, October
Published : 07, October